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AbstrAct
Objective
To estimate the direct and indirect effects of the 
covid-19 pandemic on mortality in 2020 in 29 high 
income countries with reliable and complete age and 
sex disaggregated mortality data.
Design
Time series study of high income countries.
setting
Austria, Belgium, Czech Republic, Denmark, England 
and Wales, Estonia, Finland, France, Germany, 
Greece, Hungary, Israel, Italy, Latvia, Lithuania, the 
Netherlands, New Zealand, Northern Ireland, Norway, 
Poland, Portugal, Scotland, Slovakia, Slovenia, South 
Korea, Spain, Sweden, Switzerland, and United States.
ParticiPants
Mortality data from the Short-term Mortality 
Fluctuations data series of the Human Mortality 
Database for 2016-20, harmonised and disaggregated 
by age and sex.
interventiOns
Covid-19 pandemic and associated policy measures.
Main OutcOMe Measures
Weekly excess deaths (observed deaths versus 
expected deaths predicted by model) in 2020, by sex 
and age (0-14, 15-64, 65-74, 75-84, and ≥85 years), 
estimated using an over-dispersed Poisson regression 
model that accounts for temporal trends and seasonal 
variability in mortality.
results
An estimated 979 000 (95% confidence interval 
954 000 to 1 001 000) excess deaths occurred in 
2020 in the 29 high income countries analysed. All 
countries had excess deaths in 2020, except New 
Zealand, Norway, and Denmark. The five countries 
with the highest absolute number of excess deaths 
were the US (458 000, 454 000 to 461 000), Italy 
(89 100, 87 500 to 90 700), England and Wales 
(85 400, 83 900 to 86 800), Spain (84 100, 82 800 to 
85 300), and Poland (60 100, 58 800 to 61 300). New 
Zealand had lower overall mortality than expected 
(−2500, −2900 to −2100). In many countries, the 
estimated number of excess deaths substantially 
exceeded the number of reported deaths from 
covid-19. The highest excess death rates (per 
100 000) in men were in Lithuania (285, 259 to 311), 
Poland (191, 184 to 197), Spain (179, 174 to 184), 
Hungary (174, 161 to 188), and Italy (168, 163 to 
173); the highest rates in women were in Lithuania 
(210, 185 to 234), Spain (180, 175 to 185), Hungary 
(169, 156 to 182), Slovenia (158, 132 to 184), and 
Belgium (151, 141 to 162). Little evidence was found 
of subsequent compensatory reductions following 
excess mortality.
cOnclusiOn
Approximately one million excess deaths occurred 
in 2020 in these 29 high income countries. Age 
standardised excess death rates were higher in men 
than women in almost all countries. Excess deaths 
substantially exceeded reported deaths from covid-19 
in many countries, indicating that determining the 
full impact of the pandemic on mortality requires 
assessment of excess deaths. Many countries had 
lower deaths than expected in children <15 years. 
Sex inequality in mortality widened further in most 
countries in 2020.
Introduction
During the SARS-CoV-2 pandemic, national govern-
ments have reported the number of deaths from 
covid-19, often on a daily basis. However, widespread 
heterogeneity exists in the accuracy and completeness 
of reported deaths from covid-19 across countries and 
jurisdictions.1 2 Measures taken to handle the covid-19 
pandemic have also varied substantially across 
countries.1 3-8 Therefore, assessment of the full impact 
of the pandemic on mortality should include both the 
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WhAt Is AlreAdy knoWn on thIs topIc
Assessment of the full impact of the pandemic on mortality in different 
populations should include both its direct effect on deaths from covid-19 and its 
indirect effect on deaths from other diseases
This requires estimation of “excess deaths”—the difference between the number 
of deaths from all causes during the pandemic and the expected number of 
deaths given a historical baseline from recent years
Studies reporting on excess mortality have not accounted for temporal and 
seasonal trends, or differences in the age and sex composition, across the 
countries when estimating excess mortality
WhAt thIs study Adds
The five countries with the highest absolute number of excess deaths were the 
US, Italy, England and Wales, Spain, and Poland; New Zealand had lower overall 
mortality than expected
The highest excess death rates (per 100 000) in men were in Lithuania, Poland, 
Spain, Hungary, and Italy; the highest rates in women were in Lithuania, Spain, 
Hungary, Slovenia, and Belgium
Accounting for difference in age, the excess death rates were much higher in men 
than women in almost all countries
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direct effect of the pandemic on deaths from covid-19 
and the indirect effect of the pandemic on deaths from 
other causes, as might be expected from the disruption 
to health services or from wider economic and social 
changes.9-17
Assessing the overall impact of the pandemic on 
mortality requires measurement of “excess deaths,” 
calculated as the difference between the number of 
deaths from all causes that occurred during the course 
of the pandemic and the expected number of deaths 
based on a historical baseline from recent years.18-21 
Mortality below the expected levels is called “avoided 
mortality” or “mortality deficit,” whereas “mortality 
displacement” (or “harvesting”) is characterised 
by a period of excess deaths followed by a period 
of mortality deficit (see glossary in supplementary 
materials for more information).13 22 Mortality 
displacement indicates that people who have died 
during the course of an event (in this case, the covid-19 
pandemic) would have died soon after in the absence 
of the event (that is, their death was brought forward 
by a short period). Previous studies have varied in their 
use of historical baselines to calculate excess deaths. 
Some have compared deaths during the pandemic with 
those reported in 2019 or with a simple average of the 
preceding few years.20 However, estimates of expected 
deaths should ideally account for recent temporal 
trends in mortality that are likely to have occurred in 
the absence of the pandemic.21 23 24
Focusing on excess deaths from all causes also 
reduces the potential for misclassification of deaths 
from covid-19 and other causes, which facilitates 
comparisons between countries.18-21 The reliable 
ascertainment of deaths from covid-19 depends on 
widespread testing for covid-19 and on the methods 
used to assign cause of death, both of which vary 
between countries.1 2 In addition, as the case fatality 
from covid-19 is strongly related to age, comparisons 
between countries should account for this by stratifying 
or standardising excess deaths for age.25 26
We report the findings on excess deaths from the 
covid-19 pandemic in 29 countries after accounting for 
temporal trends and seasonal variations in mortality 
within countries, and for demographic differences 
between countries, to give age and sex specific excess 
mortality in each country during 2020.
Methods
study design
We did a time series analysis of weekly mortality data 
collected from 29 member countries of the Organisation 
for Economic Cooperation and Development (OECD). 
Data for this study came from the Human Mortality 
Database. The database collates mortality and 
population data from authoritative national agencies 
and is maintained by the Department of Demography 
at the University of California, Berkeley, USA, and the 
Max Planck Institute for Demographic Research in 
Rostock, Germany.27 28 Data are made available in a 
standardised format for each country, disaggregated 
by age and sex.
Since the start of the covid-19 pandemic, weekly 
national mortality data have been collected from many 
of the countries represented in the database, to support 
objective and comparable assessments of the scale of 
short term variations in mortality (Short-term Mortality 
Fluctuations data series). We used age and sex specific 
mortality data from this series. Further details on the 
sources of data and on the methods for collection and 
standardisation of data for the series are available in 
the supplementary table S1.29 30
Weekly mortality data were available for most OECD 
countries in the database for the period 2016-19, but 
delays in registration of vital events meant that weekly 
mortality data for some countries were available for only 
part of 2020. We restricted our analyses to 29 countries 
with complete weekly data in 2020 (52 weeks). Weekly 
mortality data were available by sex and by 5 year 
age groups (0-4, 5-9, 10-14, 85-89, ≥90 years) in 23 
countries and by sex and broad age groups (0-14, 15-
64, 65-74, 75-84, and ≥85 years) for the remaining six 
countries (England and Wales (combined), Germany, 
Israel, South Korea, New Zealand, and the US).
statistical analysis
For each country, we compared the age and sex specific 
number of deaths in each week in 2020 (“observed 
weekly deaths”) with the age and sex specific number 
of expected deaths in each week given historical 
trends, to estimate the weekly number of excess 
deaths. We estimated weekly expected deaths by using 
an over-dispersed Poisson model that accounts for 
temporal trends and seasonal and natural variability 
in mortality.23 The model has been validated in 
simulation and when using historical data.23
For each age and sex specific group in a given 
country, the model used mortality data for 2016-19 to 
estimate the expected number of deaths in each group 
for each week of 2020. To ameliorate the influence 
of past major events on these estimates, past periods 
(2016-19) with atypical mortality (for example, heat 
waves, influenza outbreak) were excluded from the 
model (supplementary table S2).
Specifically, let Ys,c,a(t) be the number of deaths at 
week (t) for individuals of sex (s), in country (c), and age 
group (a). Note that (s) represents either female or male, 
(c) can be any of the 29 OECD countries, and (a) takes 
on any of the aforementioned age groups. Assuming 
that Ys,c,a(t) ~Poisson(µs,c,a(t)), our mean model is:
•	 µs,c,a(t)=Ns,c,a(t)exp{βt+gs,c,a(wt)} for t ∈ Ic (1)
The expected number of deaths at week (t) for 
individuals of sex (s), in country (c), and age group 
(a) is represented with µs,c,a(t); Ns,c,a(t) is an offset that 
accounts for the population size; β represents a linear 
effect of time that accounts for slow moving changes 
in mortality; gs,c,a(wt) is a function that accounts for 
seasonal trends, where wt ∈ {1, 52} represents a week 
of the year; and (Ic) is a country specific training 
interval that is used to fit the model. For the smooth 
estimates of percentage change from average, let (t’) be 
a week in 2020; then:
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•	 λs,c,a(t’)=μ^s,c,a(t’)exp{fs,c,a(t’)} (2)
In model (2), λs,c,a(t’) represents the average number 
of observed deaths at week (t’) for individuals of sex 
(s), in country (c), and age group (a). The number of 
deaths at week (t’) in the counterfactual scenario of no 
pandemic is represented with μ^s,c,a(t’) and it is used 
as an offset. Lastly, the function fs,c,a(t’) is a natural 
cubic spline with 12 internal knots. It follows that 
γ^s,c,a(t’)=λ^s,c,a(t’)/μ^s,c,a(t’)−1 represents a smooth esti-
mate of percentage change from average at t’. We used 
the excessmort R package to fit our modelling scheme 
and provide a detailed description of the model in the 
supplementary methods.
We report the excess deaths and excess death rates in 
each country overall, by sex, and by age. To avoid a false 
sense of precision,21 numbers <1000 are rounded to the 
nearest ten, numbers between 1000 and <100 000 are 
rounded to the nearest hundred, and those ≥100 000 
are rounded to the nearest thousand. To facilitate the 
comparison of excess deaths between countries, the age 
and sex specific excess death rates in each country for 
2020 were directly standardised to the 2013 European 
standard population to calculate the age standardised 
excess death rate in each country in males and females.31 
We produced age standardised rates by using 5 year age 
groups for 19 countries but broad age groups (0-14, 
15-64, 65-74, 75-84, and ≥85 years) for the remaining 
countries for which either data by 5 year age groups were 
not available or the weekly age and sex specific death 
counts were too small (such as in Estonia, Lithuania, 
Northern Ireland, and Norway). Rates in the broad age 
groups were adjusted, using methods developed by 
the Max Planck Institute for Demographic Research on 
data from the core Human Mortality Database, to those 
that would be expected given the age distribution of 
the standard population; they were thus comparable to 
rates calculated using 5 year age groups.32
We also compared the overall number of estimated 
excess deaths with the reported number of deaths 
from covid-19 in each country (source: covid-19 time 
series data collated by Johns Hopkins University Center 
for Systems Science and Engineering, available at 
https://github.com/datasets/covid-19/tree/main/
data). We used RStudio (version 1.4.1103) and Stata 
SE (v.15.1) for all statistical analyses. All data used 
in this analysis are fully anonymised and aggregated 
without any identifiable information.
Patient and public involvement
The rapid nature of this research project in the 
context of the ongoing covid-19 pandemic meant that 
participants were not involved in the development of 
the research question or the outcome measures, or in 
the design or implementation of the study; neither 
were participants asked to advise on the interpretation 
or writing of the manuscript. However, the findings 
will be widely disseminated to the public through 
official channels (press release, blogs, institutional 
websites, and repositories), personal communications, 
and social communication tools.
results
excess deaths
Table 1 shows the estimated number of excess deaths 
in 2020 for the 29 countries included in the analysis, 
overall and separately for men and women. All 
countries had excess deaths for 2020, except Norway 
and Denmark, for which we found no evidence of a 
difference between the observed and expected number 
of deaths, and New Zealand, for which we found 
evidence of fewer observed than expected deaths. 
Overall, we estimated that about one million (979 000, 
95% confidence interval 954 000 to 1 001 000) excess 
deaths occurred in the 29 countries analysed. The five 
countries with the highest absolute number of excess 
deaths were the US (458 000, 454 000 to 461 000), 
Italy (89 100, 87 500 to 90 700), England and Wales 
(85 400, 83 900 to 86 800), Spain (84 100, 82 800 
to 85 300), and Poland (60 100, 58 800 to 61 300), 
whereas New Zealand had lower overall mortality than 
expected (−2500, −2900 to −2100). In most countries, 
the number of excess deaths was somewhat higher in 
men than in women.
The estimated number of excess deaths by age groups 
in men and women are available in supplementary 
table S3. Observed deaths in children <15 years were 
similar to the expected levels in most countries and 
lower than expected in some countries (for example, 
England and Wales, France, Israel, Italy, New Zealand, 
South Korea, and the US). The total number of excess 
deaths was largely concentrated among people aged 
≥75 years, followed by people aged 65-74 years. Excess 
deaths in people aged 15-64 years were generally 
lower than in the older age groups with the exception 
of the US, where the total number of excess deaths was 
approximately 131 000 in people aged 15-64 years 
(91 500 (90 200 to 92 800) in men and 39 500 (38 500 
to 40 500) in women), higher than those estimated 
among people aged 65-74 and 75-84 years. New 
Zealand had lower than expected deaths across all the 
age groups.
The distribution of excess deaths over time varied 
by country. Figure 1 shows the estimated monthly 
(aggregated from the weekly estimates) excess deaths 
(per 100 000 population) in 2020 for men and women, 
and figure 2 shows the percentage deviation from the 
expected deaths across weeks of 2020. Some countries 
did not see major increases in excess deaths at any 
point during 2020, including Denmark, Norway, South 
Korea, and New Zealand. Other countries reported 
one or more major waves of excess deaths, after which 
excess mortality fell to lower levels.
Consistent with the timing of known peaks of 
covid-19 infection, many countries had major 
waves of excess deaths in the northern hemisphere 
spring (March-May) and in autumn-winter (October-
December). In spring, the level of excess deaths was 
particularly high (with some weeks of >50% excess 
deaths) in Italy, Spain, England and Wales, Scotland, 
Northern Ireland, Belgium, and the Netherlands. 
In autumn-winter, levels of excess deaths were 
particularly high in Austria, Belgium, Czech Republic, 
 on 20 M













J: first published as 10.1136/bm






4 doi: 10.1136/bmj.n1137 | BMJ 2021;373:n1137 | the bmj
Hungary, Italy, Lithuania, Poland, Slovakia, Slovenia, 
and Switzerland. Within countries, we found little 
evidence of a difference between men and women in 
trends over time in the proportional increases in excess 
deaths in 2020.
In some countries, during some periods of the year, 
the observed number of deaths fell below the expected 
number of deaths, most notably in New Zealand in 
the middle of the year. Detailed age and sex specific 
estimated number of excess deaths and percentage 
deviation from expected deaths over time are provided 
in supplementary figure S1 (A-E) and supplementary 
figure S2 (A-E), respectively. Although excess mortality 
was higher in the older age groups in most of the 
countries, the observed mortality was lower than 
expected in children <15 years in many countries.
crude and age standardised excess death rates
Figure 3 shows the age specific excess death rates 
(per 100 000) in each country, separately in men 
and women. The excess death rate increased 
exponentially with age in both sexes, except in those 
countries with no evidence of excess deaths, for 
which we observed a reduction in excess death rates 
at older ages; a particularly marked reduction in 
excess death rates occurred in New Zealand at ages 
≥65 years. In most countries, age specific excess 
death rates were higher in men than in women, 
and the absolute difference in rates between the 
sexes tended to increase with age. However, in the 
US, in contrast to other countries, the excess death 
rate (per 100 000) was higher among women (1899, 
1855 to 1943) than men (1719, 1653 to 1784) at 
ages ≥85 years.
Figure 4 shows the crude and age standardised 
excess death rates in men and women. The highest 
crude excess death rates (per 100 000) in men were in 
Lithuania (285, 259 to 311), Poland (191, 184 to 197), 
Spain (179, 174 to 184), Hungary (174, 161 to 188), 
and Italy (168, 163 to 173); the highest rates in women 
were in Lithuania (210, 185 to 234), Spain (180, 175 
to 185), Hungary (169, 156 to 182), Slovenia (158, 
132 to 184), and Belgium (151, 141 to 162). Although 
we found little evidence of differences between men 
and women in the crude excess death rates in 2020, 
almost all countries with excess deaths had higher age 
standardised rates for men than women (fig 4). The age 
standardised rates also varied substantially within men 
and women across the countries analysed. The highest 
age standardised excess death rates (per 100 000) in 
men were in Lithuania (360, 324 to 396), Poland (298, 
289 to 307), Hungary (235, 217 to 254), Slovenia 
(222, 189 to 256), and the Czech Republic (211, 194 
to 228); the highest age standardised rates in women 
were in Lithuania (152, 134 to 171), Hungary (144, 
133 to 156), the US (131, 129 to 133), Spain (125, 
121 to 129), and Northern Ireland (121, 97 to 146). 
The lowest age standardised excess mortality rates for 
both men and women were in New Zealand, Denmark, 
Norway, South Korea, and Finland.
table 1 | estimated number of excess deaths in 2020 in 29 high income countries, by sex
country total no (95% ci) no (95% ci) male no (95% ci) female
United States 458 000 (454 000 to 461 000) 245 000 (243 000 to 247 000) 213 000 (210 000 to 215 000)
Italy 89 100 (87 500 to 90 700) 49 000 (47 900 to 50 000) 40 200 (39 000 to 41 300)
England and Wales 85 400 (83 900 to 86 800) 45 000 (44 000 to 46 000) 40 400 (39 400 to 41 400)
Spain 84 100 (82 800 to 85 300) 41 100 (40 200 to 42 000) 43 000 (42 100 to 43 800)
Poland 60 100 (58 800 to 61 300) 35 400 (34 500 to 36 300) 24 700 (23 800 to 25 600)
France 43 500 (42 000 to 45 000) 24 600 (23 500 to 25 700) 18 900 (17 800 to 20 000)
Germany 25 900 (24 000 to 27 800) 17 700 (16 400 to 19 000) 8200 (6900 to 9600)
Belgium 17 900 (17 200 to 18 500) 9000 (8600 to 9500) 8800 (8400 to 9300)
Hungary 16 600 (15 900 to 17 300) 8100 (7600 to 8500) 8500 (8000 to 9000)
Netherlands 15 300 (14 600 to 16 100) 8800 (8200 to 9300) 6500 (6000 to 7100)
Czech Republic 14 400 (13 700 to 15 000) 8000 (7500 to 8500) 6400 (5900 to 6900)
Sweden 9300 (8700 to 9800) 5100 (4700 to 5500) 4100 (3700 to 4500)
Portugal 8500 (7800 to 9100) 4000 (3500 to 4500) 4500 (4000 to 5000)
Greece 7700 (7000 to 8300) 3500 (3100 to 4000) 4100 (3600 to 4600)
Austria 6800 (6200 to 7300) 3800 (3400 to 4200) 2900 (2500 to 3300)
Scotland 6800 (6400 to 7300) 3900 (3600 to 4200) 2900 (2600 to 3300)
Switzerland 6800 (6300 to 7300) 4000 (3700 to 4400) 2800 (2400 to 3200)
Lithuania 6800 (6500 to 7200) 3700 (3500 to 4000) 3100 (2800 to 3400)
Slovakia 4400 (4000 to 4900) 2300 (2000 to 2700) 2100 (1800 to 2400)
South Korea 4000 (2900 to 5000) 1800 (1000 to 2600) 2200 (1400 to 2900)
Slovenia 3200 (3000 to 3500) 1600 (1400 to 1800) 1600 (1400 to 1800)
Northern Ireland 2200 (1900 to 2400) 1000 (860 to 1200) 1100 (980 to 1300)
Israel 2000 (1600 to 2400) 1300 (1000 to 1600) 690 (400 to 990)
Finland 1000 (550 to 1500) 690 (360 to 1000) 320 (0 to 640)
Latvia 820 (490 to 1100) 270 (50 to 490) 550 (310 to 790)
Estonia 670 (430 to 910) 330 (160 to 490) 340 (170 to 520)
Norway −70 (−470 to 320) 100 (−180 to 370) −170 (−450 to 110)
Denmark −160 (−610 to 300) −40 (−360 to 290) −120 (−440 to 200)
New Zealand −2500 (−2900 to −2100) −1200 (−1500 to −970) −1300 (−1500 to −1000)
Excess deaths in 2020 calculated as difference in observed deaths and expected deaths predicted using over-dispersed Poisson model that accounts for temporal trends and seasonal and 
natural variability. Numbers <1000 are rounded to nearest ten; numbers between 1000 and <100 000 are rounded to nearest hundred, and numbers ≥100 000 are rounded to nearest thousand.
Data: Short-term Mortality Fluctuations data series of Human Mortality Database
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Fig 1 | Monthly excess deaths (per 100 000) in 29 high income countries in 2020, all ages, by sex. excess deaths in 2020 were calculated as 
difference in observed deaths and expected deaths predicted using over-dispersed Poisson model that accounts for temporal trends and seasonal 
and natural variability. estimated excess deaths for each week of 2020 were aggregated into months. Data: short-term Mortality Fluctuations data 
series of Human Mortality Database
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Fig 2 | Weekly percentage deviation from expected deaths in 29 countries in 2020, all ages, by sex. Weekly percentage deviation of observed deaths 
versus expected deaths predicted using over-dispersed Poisson model that accounts for temporal trends and seasonal and natural variability. 
Percentage changes from mean during study period were modelled using smooth function of time. Data: short-term Mortality Fluctuations data 
series of Human Mortality Database
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Fig 3 | excess death rates in 29 high income countries in 2020, by sex and age. excess death rate (per 100 000) in 2020 was calculated as difference 
in observed deaths and expected deaths predicted using over-dispersed Poisson model that accounts for temporal trends and seasonal and natural 
variability. age standardised within each age group. Data: short-term Mortality Fluctuations data series of Human Mortality Database
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comparison of estimated excess deaths and 
reported covid-19 deaths
In most countries, the estimated number of excess 
deaths exceeded the number of reported deaths from 
covid-19 (table 2). For example, in both the US and 
the UK (that is, England, Wales, Northern Ireland, 
and Scotland combined), the estimated excess deaths 
were more than 30% higher than the number of 
reported covid-19 deaths, and they were more than 
50% higher in some other countries, including Spain, 
Poland, Hungary, Greece, Lithuania, Slovakia, Estonia, 
and South Korea. However, New Zealand, Norway, 
Denmark, Israel, France, Germany, Belgium, and 
Switzerland had a higher number of reported covid-19 
deaths than estimated excess deaths.
annual mortality 2016-20
The impact of the pandemic on trends in annual 
mortality rates for men and women in 2016-20 for each 
country is shown in supplementary figure S3. Men had 
consistently higher age standardised mortality rates 
than women across the period in all the countries. In 
general, age standardised mortality rates declined 
from 2016 to 2019, in both men and women. Whereas 
Denmark, Finland, South Korea, Norway, and New 
Zealand continued to show reduced mortality rates 
in 2020, most other countries experienced a marked 
increase in rates in both men and women, together 
with a widening of the gaps in mortality rates between 
the sexes. Sex specific annual mortality rates are 
shown for age groups 0-14, 15-64, 65-74, 75-84, and 
≥85 years in supplementary figure S4 (A-E).
Model fit
Supplementary figure S5 (A-B) shows the weekly 
percentage deviation from model predicted excess 
deaths in 2016-20, along with the 95% confidence 
intervals, separately for males and females. It shows 
that the relative excess deaths fluctuated around zero 
between 2016 and 2019 in most countries indicating 
goodness of fit with a median of the median absolute 
deviation of 0.059 (interquartile range 0.042-0.068) 
(detailed country specific estimates, separately in 
males and females, are provided in supplementary 
table S4). However, some periods of moderate increase 
in excess mortality occurred during some winter 
months in some countries, consistent with known 
periods of excess mortality from seasonal influenza. 
We excluded these periods from the time periods used 
to estimate the counterfactual expected mortality 
(list of country specific dates excluded is available in 
supplementary table S2).
discussion
In this international comparative study of excess 
deaths in relation to the covid-19 pandemic in 29 high 
income countries, all countries had excess deaths in 
2020, except New Zealand, Norway, and Denmark. The 
highest excess deaths were in the US, Italy, England 
and Wales, Spain, and Poland. The highest excess 
death rates in men were in Lithuania, Poland, Spain, 
Hungary, and Italy; the highest rates in women were 
in Lithuania, Spain, Hungary, Slovenia, and Belgium. 
Total deaths were below the expected level in New 
Zealand. Even though little sex difference existed in 
terms of total number or crude excess death rates, the 
age standardised excess death rate was noticeably 
higher in men than in women in most countries except 
New Zealand, Denmark, South Korea, Greece, Norway, 
Finland, Estonia, Northern Ireland, and Latvia. Most 
of the countries had underreporting of deaths from 
covid-19, an increase in non-covid-19 deaths, or a 
combination of both. On the other hand, the estimated 
number of excess deaths was lower than the reported 
covid-19 deaths in some countries (for example, Israel, 
France, Germany) owing to a reduction in non-covid-19 
deaths in specific subgroups of the population (see 
supplementary methods for more details). Despite a 
recent trend of declining annual mortality rate between 
2016 and 2019, the annual mortality rate increased 
substantially in 2020 in most of the countries, in both 
men and women. A similar trend was observed in sex 
differences in annual age standardised mortality rates.
comparison with previous literature
Several previous studies have reported country specific 
excess deaths for the first few months of 2020.18 19 21 33-36 
Mortality in younger age groups was reported to be 
at or lower than expected levels, which is consistent 
with our findings.19 20 Estimated excess deaths in the 
US are consistent with the projections of more than 
400 000 excess deaths and recent estimates produced 
by the US Centers for Disease Control and Prevention 
(CDC).18 37 Drawing on data up to May 2020, previous 
research reported that Italy, Spain, and England and 
Wales had the highest number of excess deaths, which 
is consistent with our findings.21 38 An estimated 
47 243 excess deaths were reported in England and 
Wales up to May 2020,33 and 2400-4000 excess deaths 
were estimated to have occurred in Portugal up to 
April 2020.34 The estimated number of excess deaths 
in England (excluding Wales) was 69 925 between 21 
March and 25 December according to Public Health 
England (PHE).19 Although not directly comparable 
(our estimates include aggregate data from England 
and Wales), our estimate of excess deaths is likely 
higher than the estimates from PHE. This could largely 
be due to different methods of estimation of the 
counterfactual expected counts and the varying time 
periods used. The PHE model, like most of the models 
estimating excess deaths, used the average of the 
past few years’ data without considering the natural 
and seasonal variabilities in mortality pattern over 
the control period. Our estimate of excess deaths in 
Poland is noticeably higher than previously reported, 
which could also be attributed to a marked increase 
in mortality in October-December 2020.21 Recent 
reports, however, noted that in 2020 Poland recorded 
the highest number of deaths since the second world 
war.39 New Zealand was reported to have deaths at or 
below expected levels, which is consistent with our 
findings.21 40 Our estimates show that Sweden had the 
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highest excess deaths among the Nordic countries, 
which is also consistent with a previous report.41 Our 
estimated number of excess deaths in South Korea is 
lower than those reported by Statistics Korea.42 43 This 
is because these reports compared the mortality in 
2020 with that in 2019, whereas our model examined 
the difference in 2020 compared with the expected 
mortality based on 2016-19 data.
Previous studies reported a disproportionately 
higher toll of covid-19 mortality in men,44-46 but our 
detailed analysis showed that this could vary from 
no difference to a substantial difference across the 
29 countries. A previous study concluded that no 
sex difference existed in terms of excess deaths.21 By 
contrast, our analysis shows that many countries 
with no sex difference in terms of crude excess death 
rate did show a remarkable sex difference after 
standardisation for age. However, we observed no sex 
difference in New Zealand, Denmark, South Korea, 
Greece, Norway, Finland, Estonia, Northern Ireland, 
or Latvia, even after age standardisation.21 Among 







































































































































































































































































































































































































































Fig 4 | crude and age standardised excess death rates in 29 high income countries in 2020, by sex. excess death rate (per 100 000) in 2020 was 
calculated as difference in observed deaths and expected deaths predicted using over-dispersed Poisson model that accounts for temporal trends 
and seasonal and natural variability. age standardised, where indicated, to 2013 european standard population. bottom panel: estimates above 
horizontal line at zero indicate higher excess death rate in men. Data: short-term Mortality Fluctuations data series of Human Mortality Database
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in terms of sex inequality in age standardised excess 
death rate, with a much higher mortality rate in men 
than in women. This may be a result of a multitude of 
factors, including occupational and lifestyle factors 
between the sexes that may increase the likelihood of 
exposure to SARS-CoV-2 among men than women or 
differences in underlying comorbidities between men 
and women that might have increased the likelihood 
of death following infection.45 47-49 Many of these 
countries rank very high on the gender equality index, 
but no clear relation existed between gender equality 
and differences in age standardised excess death rate 
between men and women, with some countries that 
rank highly on gender equality indices having large 
differences between sexes and vice versa.50 51 New 
Zealand managed to keep deaths below the expected 
level in all the age groups in both men and women, with 
a corresponding narrowing of the gender inequality. 
The success in managing the covid-19 pandemic in 
New Zealand and South Korea to date may be attributed 
to their early viral elimination policies.52-54
Previous studies in the US reported that about two 
thirds of the estimated excess deaths were reported 
as deaths from covid-19,55 which is lower than our 
estimate of 74% in the US. This may be indicative of a 
better reporting of, or an increase in, covid-19 deaths, 
or a combination of both, later in the pandemic.
Our study found that the existing sex inequality 
in annual standardised mortality rate, with higher 
rates in men than in women, was further widened in 
most of the countries during the first calendar year 
of the covid-19 pandemic. A large body of research 
reported that past pandemics have also widened 
existing disparities.56-59 A reduction in mortality 
(avoided mortality) was seen in children <15 years in 
some countries in 2020, which could be associated 
with a reduction in unintentional injuries (including 
drowning and car accidents) and a lower burden of 
cardiovascular and respiratory diseases potentially 
associated with a change in lifestyle or environmental 
factors during the periods of lockdown.60-63 However, 
long term data on the cause of deaths will be needed to 
fully examine the effects, because lockdown may have 
had other unintended consequences (for example, 
worsening mental health), which may take a longer 
time to affect overall mortality.13
In contrast to other countries, the excess death rates 
in women aged ≥85 years in the US were higher than 
in their male counterparts. The exact reasons for such 
a discrepancy will require detailed exploration of the 
cause of deaths in this age group, but we propose 
some potential reasons. Firstly, according to the CDC’s 
recent estimates of cause of deaths by age and sex, 
this is the only age group in which women had higher 
table 2 | Difference between reported number of covid-19 deaths and estimated number of excess deaths associated with covid-19 pandemic in 2020 
in 29 high income countries
country
total covid-19 deaths 
reported* (a)
total excess deaths esti-
mated† (b)
Difference between excess deaths and 
reported covid-19 deaths (b–a)
ratio of excess deaths to reported cov-
id-19 deaths, % (b/a×100)
United States 339 014 458 000 118 986 135
United Kingdom‡ 70 860 94 400 23 540 133
Italy 71 925 89 100 17 175 124
Spain 49 824 84 100 34 276 169
Poland 27 118 60 100 32 982 222
France 62 867 43 500 −19 367 69
Germany 30 297 25 900 −4397 85
Belgium 19 200 17 900 −1300 93
Hungary 9047 16 600 7553 183
Netherlands 11 090 15 300 4210 138
Czech Republic 11 044 14 400 3356 130
Sweden 8279 9300 1021 112
Portugal 6619 8500 1881 128
Greece 4606 7700 3094 167
Switzerland 7210 6800 −410 94
Austria 5881 6800 919 116
Lithuania 1613 6800 5187 422
Slovakia 1773 4400 2627 248
South Korea 819 4000 3181 488
Slovenia 2565 3200 635 125
Israel 3226 2000 −1226 62
Finland 524 1000 476 191
Latvia 559 820 261 147
Estonia 204 670 466 328
Norway 421 −70 NA NA
Denmark 1174 −160 NA NA
New Zealand 25 −2500 NA NA
NA=not applicable.
*Reported covid-19 deaths in 2020 (up to 27 December 2020, end of 52nd week). Source: Unified covid-19 dataset maintained by Johns Hopkins University Center for Systems Science and 
Engineering (https://raw.githubusercontent.com/datasets/covid-19/main/data/countries-aggregated.csv).
†Total excess deaths estimated from model. Numbers <1000 are rounded to nearest ten; numbers between 1000 and <100 000 are rounded to nearest hundred, and numbers ≥100 000 are 
rounded to nearest thousand.
‡Total number of excess deaths in England and Wales, Scotland, and Northern Ireland. See supplementary methods for simpler explanation of discrepancies between reported covid-19 deaths 
and estimated excess deaths.
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death rates than men across the causes of death in 
2020—namely, covid-19 deaths (70 985 v 50 801), 
total deaths (616 124 v 393 995), pneumonia deaths 
(54 521 v 46 828), pneumonia and covid-19 deaths 
(25 989 v 23 086), influenza deaths (1065 v 734), and 
pneumonia, influenza, or covid-19 deaths (100 473 
v 75 178).64 Secondly, covid-19 deaths in US nursing 
homes have been described as catastrophic with >40% 
share of covid-19 deaths among this population that 
is only 0.6% of the total US population.65-67 Moreover, 
all cause mortality in US nursing homes had been 
decreasing until 2017.68 With the decreasing trend, 
the expected all cause mortality in 2020 would be 
lower than the 2017 estimates of 534 714 deaths.68 
However, contrary to the expectations, the all cause 
mortality increased to 585 429 in 2020, with the 
highest number of deaths occurring in the ≥85 age 
group (n=328 387).69 Thirdly, 59% of nursing home 
residents are women,70 and elderly female nursing 
home residents have a higher burden of obesity 
(36.1% v 31.8%) and hypertension (86% v 81.5%) 
than their male counterparts.71 Fourthly, as depicted 
in supplementary figure S4 (E), although all cause 
mortality rates in men ≥85 remained very similar to 
those in the past few years, the death rates in women 
≥85 years decreased sharply in 2019, but the increase 
in the death rate in 2020 was much steeper in women 
than in men. All these factors may have contributed to 
a higher estimated excess death rate in women than 
men in the ≥85 year age category in the US.
strengths and limitations of study
In this large international comparative study, we 
examined excess deaths associated with the covid-19 
pandemic in 2020 by using detailed age and sex 
specific mortality data with robust and validated 
analytical methods. Methods for estimating excess 
deaths have varied substantially. The most commonly 
used method is to compare deviations in mortality with 
the average of the preceding few years.20 Comparing 
the deaths in the timeline of interest with the simple 
average of the previous few years ignores critical 
factors such as recent general health improvement and 
decline in mortality with time, seasonal and natural 
variability, and demographic changes.23  24 More 
nuanced methods of outbreak detection modelling 
have been proposed to detect aberrations in mortality 
on the basis of historical trends.72-74 These methods 
provide a point estimate and an upper bound for 
expected deaths and produce a conservative estimate 
of excess deaths by considering counts above these 
thresholds.18 More recently, Rizzi and Vaupel proposed 
a method to “shortcast” (neologism for short term 
forecasting) the average number of deaths in the 
absence of an event that relies exclusively on death 
counts.24 Their approach is appealing owing to its 
simplicity but was applied to only four countries, 
and, as the authors specifically noted, this method is 
designed for short term forecasting. Therefore, this 
method may not be suitable for the covid-19 pandemic, 
which continues to exist more than a year after its 
emergence. Moreover, this method does not account 
for changing demographic composition. Karlinsky and 
Kobak take a much more traditional route to assessing 
excess mortality.75 For each country, they fit a linear 
regression with a slope for year and week specific 
coefficients without taking into account the possible 
changes in the population. To calculate counterfactual 
counts, they simply predict fitted values for 2020. 
Their model relies on marginal death counts without 
stratification by age or sex, and hence is limited to 
exploring the differences by two of the most important 
predictors of mortality. Our dataset is richer than that 
used by the groups described above because it provides 
more granular data by age and sex in a large number of 
countries. Furthermore, our statistical model does not 
have the aforementioned limitations. We accounted for 
changes in the demographic profile of all countries by 
using age and sex specific population estimates.
A unique strength of the database is the use of the 
authoritative national agencies for data collection, 
extensive checks and data validation procedures, 
comparability across countries and time, highly 
detailed and uniform data formats, and availability of 
data on survival to the highest ages. However, we were 
limited to an analysis of countries that reported weekly 
deaths by age and sex for the entire study period of 
2016-20. We acknowledge that no consensus exists 
in the literature on the historical time period for the 
estimation of the counterfactual expected deaths. We 
were also limited by the completeness of the data (for 
example, Canada and Australia have not yet reported 
complete data in 2020).
As highlighted previously, the variability around 
the estimated excess death in children <15 years is 
larger than in other age groups owing to sparse data.24 
To make the analysis comparable, we presented our 
findings by five broader age groups. The 15-64 years 
age group represents the working age group, but it 
also consists of heterogeneous age groups in terms of 
risk of mortality. In an exploratory analysis, the rate 
of excess deaths was smaller in age groups <45 years 
but varied markedly in age groups 45-54 and 55-64 
years (supplementary figure S6). Excess risk was also 
relatively low in females across all age groups (except 
in Hungary, where the rate was higher in women 
aged 55-64 years). Belgium, the Czech Republic, 
Hungary, Poland, and Scotland had the highest excess 
death rates in men aged 55-64 years (exceeding 100 
excess deaths per 100 000). The aggregated analysis 
essentially masks these nuanced trends in mortality 
rates.
We did not have the data to examine the variability 
in excess deaths by other potentially critical factors 
such as ethnicity and socioeconomic status.45 59 76-81 
We also did not examine within country regional 
differences in mortality owing to unavailability of such 
granular data. Even though we assumed a fairly stable 
population during 2020 within each country, some 
in-country migration or displacement could occur 
as a result of changes in job or financial situations. 
Although this assumption will more likely hold true for 
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most countries, an underestimation of such population 
displacement may have resulted in an underestimation 
of excess deaths.23 Our analysis is restricted to the 
end of 2020 to make our estimates by calendar year 
comparable to the conventional mortality statistics 
reported by international agencies including the 
World Health Organization and the United Nations. 
Therefore, our study does not reflect the excess deaths 
experienced by some countries in early 2021. The 
indirect effects of a pandemic and its associated policy 
measures are multifactorial.13 Many of these may need 
a longer timeframe to have a measurable effect on 
mortality. Our analysis was unable to measure these 
effects. Also, we did not have access to individual 
patient level data to explore the cause of deaths, which 
would provide important insights about the sources 
and potential mechanisms of the direct and 
indirect effects of the pandemic and its associated 
policy measures.13 Although no visible mortality 
displacement occurred in our study, mortality 
displacement in one group may be masked by the 
ongoing excess mortality in other population groups. 
More studies with longer follow-up data are needed to 
disentangle this phenomenon.
Policy implications and future directions
Our study adds important insights on the direct and 
indirect effects of the covid-19 pandemic on total 
mortality. It underscores the importance of availability 
of age and sex disaggregated data for more nuanced 
analysis and estimation of the direct and indirect effect 
of the pandemic. A lack of detailed data from lower 
and middle income countries, especially those in Asia 
and Africa, calls for a globally coordinated effort to 
improve the local capacity in collecting and reporting 
critical vital statistics data promptly to aid evidence 
based healthcare policy decisions. New Zealand stood 
out as the only country that had a lower than expected 
mortality across all the age groups, in both men and 
women, with no sex difference in excess death rates, 
which could potentially be attributed to the country’s 
elimination strategy early in the pandemic.52 53 Our 
findings also suggest that many countries had an 
underestimation or underreporting of covid-19 deaths, 
a substantial increase in non-covid-19 deaths, or both. 
Reliable and timely monitoring of excess deaths would 
help to inform public health policy in investigating 
the sources of excess mortality in populations and 
would help to detect important social inequalities in 
the impact of the pandemic to inform more targeted 
interventions.82
Our study also highlights the need for nuanced 
analysis taking into account the other potential 
sources of social inequalities including ethnicity and 
socioeconomic status. This study provides a detailed 
and robust assessment of the impact of the covid-19 
pandemic on total mortality up to the point that mass 
vaccination programmes started to become widely 
available throughout these countries. Future work 
will be needed to understand the impact of national 
vaccination programmes on mortality in 2021.
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